Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AktiengesellschaftfiledCriticalBayer Aktiengesellschaft
Priority to YU53596ApriorityCriticalpatent/YU53596A/sh
Publication of YU53596ApublicationCriticalpatent/YU53596A/sh
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Pronalazak se odnosi na citostatike, koji su usled modifikovanja sa šećerom specifični za tumor. Pogodni razdeonik (spejser) obezbedjuje stabilnost seruma, a jednovremeno i intraćelijsko delovanje.
YU53596A1996-10-011996-10-01Citostatici modifikovani sa ugljenim hidratima
YU53596A
(sh)